Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosis
Randomized Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosis
Sherief Abd-Elsalam
100 participants
Jan 1, 2015
INTERVENTIONAL
Conditions
Summary
Muscle cramps are common in patients with liver disease and associated with significantly diminished quality of life. Patients with cirrhosis often experience muscle cramps with varied frequency and severity. The exact mechanisms by which they occur remain unclear, although a number of pathophysiological events unique to liver disease may contribute. Clinical studies have identified alterations in 3 areas: nerve function, energy metabolism, and plasma volume/electrolytes (1) Orphenadrine is an anticholinergic drug with prominent central nervous system (CNS) and peripheral actions used to treat painful muscle spasms and other similar conditions. The combination of anticholinergic effects and CNS penetration make orphenadrine useful for pain of all etiologies, including from: radiculopathy, muscles, and headaches. \[3,4\]
Eligibility
Inclusion Criteria2
- Cirrhosis
- Muscle cramps( ≥3 cramps per week )
Exclusion Criteria6
- • Allergy to orphenadrine
- Renal impairment
- Pregnant and lactating women
- Peripheral vascular disease
- Peripheral neuropathy
- Medications as calcium channel blockers, conjugated estrogens and naproxen. Glaucoma Prostatic enlargement
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Orphenadrine in muscle cramps in cirrhotic patients
calcium in muscle cramps in cirrhotic patients
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02423395